Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
OMNIPAQUE 180 GE HEALTHCARE CANADA INC Resolved 388MG Updated Report 2022-08-06 163556
TEPMETKO EMD SERONO, A DIVISION OF EMD INC., CANADA Actual shortage 225MG Updated Report 2022-08-06 164239
TOBRADEX NOVARTIS PHARMACEUTICALS CANADA INC Resolved 0.1% 0.3% Updated Report 2022-08-06 165184
STERILE WATER FOR IRRIGATION USP ICU MEDICAL CANADA INC Actual shortage 100% Updated Report 2022-08-06 165752
APO-DORZO-TIMOP APOTEX INC Resolved 5MG 20MG Updated Report 2022-08-06 161037
MERSYNDOL WITH CODEINE SANOFI-AVENTIS CANADA INC Resolved 5MG 8MG 325MG Updated Report 2022-08-06 164562
METHYLDOPA AA PHARMA INC Actual shortage 250MG Updated Report 2022-08-06 164606
APO-LEVOFLOXACIN APOTEX INC Resolved 500MG Updated Report 2022-08-06 164728
APO-GUANFACINE XR APOTEX INC Resolved 2MG Updated Report 2022-08-06 165317
APO-GUANFACINE XR APOTEX INC Resolved 4MG Updated Report 2022-08-06 165322

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
HEPTOVIR GLAXOSMITHKLINE INC To be discontinued 100MG Updated Report 2022-08-05 160500
AMERGE GLAXOSMITHKLINE INC To be discontinued 1MG Updated Report 2022-08-05 148427
KEVZARA SANOFI-AVENTIS CANADA INC Discontinued 150MG Updated Report 2022-08-02 164491
GLUCAGON ELI LILLY CANADA INC To be discontinued 1MG New Report 2022-07-29 165759
SINEMET ORGANON CANADA INC. Discontinued 250MG 25MG New Report 2022-07-29 165740
SINEMET ORGANON CANADA INC. Discontinued 100MG 25MG New Report 2022-07-29 165737
BYETTA ASTRAZENECA CANADA INC Discontinued 5MCG Updated Report 2022-07-27 154100
AURALGAN PALADIN LABS INC. Discontinued 54MG 14MG Updated Report 2022-07-26 165407
PMS-VENLAFAXINE XR PHARMASCIENCE INC Discontinued 75MG New Report 2022-07-25 165500
PMS-VENLAFAXINE XR PHARMASCIENCE INC Discontinued 150MG New Report 2022-07-25 165495
PMS-VENLAFAXINE XR PHARMASCIENCE INC Discontinued 75MG New Report 2022-07-25 165490
PMS-VENLAFAXINE XR PHARMASCIENCE INC Discontinued 37.5MG New Report 2022-07-25 165485
PMS-VENLAFAXINE XR PHARMASCIENCE INC Discontinued 150MG New Report 2022-07-25 165480
PMS-VENLAFAXINE XR PHARMASCIENCE INC Discontinued 37.5MG New Report 2022-07-25 165475
PMS-ZOLMITRIPTAN ODT PHARMASCIENCE INC Discontinued 2.5MG New Report 2022-07-25 165469
PMS-FENTANYL MTX PHARMASCIENCE INC To be discontinued 12MCG New Report 2022-07-25 165462
PMS-FENTANYL MTX PHARMASCIENCE INC To be discontinued 12MCG New Report 2022-07-25 165397
HEPTOVIR GLAXOSMITHKLINE INC Discontinued 5MG Updated Report 2022-07-22 160503
PIPERACILLIN AND TAZOBACTAM FOR INJECTION HIKMA CANADA LIMITED To be discontinued 0.5G 4G New Report 2022-07-21 165196
PIPERACILLIN AND TAZOBACTAM FOR INJECTION HIKMA CANADA LIMITED To be discontinued 0.375G 3G New Report 2022-07-21 165193